Alpha-Lipoic Acid in Mitigating Cisplatin-Induced Nephrotoxicity

Clinical trial NCT07564479 · RECRUITING

Trial details

NCT number: NCT07564479
Sponsor: Minia University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Cisplatin Nephrotoxicity Nephrotoxicity

Start date: 2026-03-10
Primary completion: 2027-03-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.